Bryone J. Kuss
- Genetics top 2%
- Pathology and Forensic Medicine top 5%
- Molecular Biology
- Hematology top 5%
- Oncology top 10%
- Co-authors
- Constantine S. TamMagdalena Sobieraj‐TeagueCraig T. Wallington‐BeddoeStuart M. PitsonSinoula ApostolouNicolas H. VoelckerPaolo GhiaStephen Opat
- Topics
- Chronic Lymphocytic Leukemia Research (48 papers)Lymphoma Diagnosis and Treatment (27 papers)Immunodeficiency and Autoimmune Disorders (12 papers)
- Journals
- The LancetJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- AustraliaUnited StatesItaly
In The Last Decade
Bryone J. Kuss
75 papers receiving 966 citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Genetics 500
- Pathology and Forensic Medicine 357
- Molecular Biology 315
- Hematology 279
- Oncology 235
Countries citing papers authored by Bryone J. Kuss
This map shows the geographic impact of Bryone J. Kuss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryone J. Kuss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryone J. Kuss more than expected).
Fields of papers citing papers by Bryone J. Kuss
This network shows the impact of papers produced by Bryone J. Kuss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryone J. Kuss. The network helps show where Bryone J. Kuss may publish in the future.
Co-authorship network of co-authors of Bryone J. Kuss
This figure shows the co-authorship network connecting the top 25 collaborators of Bryone J. Kuss. A scholar is included among the top collaborators of Bryone J. Kuss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryone J. Kuss. Bryone J. Kuss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohortbreakdown → | 124 |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 8 | |
| 5 | 2 | |
| 6 | 11 | |
| 7 | 33 | |
| 8 | 3 | |
| 9 | 31 | |
| 10 | Effect of dose modifications on response to duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma in the DUO trial | 1 |
| 11 | 1 | |
| 12 | 34 | |
| 13 | 12 | |
| 14 | 3 | |
| 15 | 15 | |
| 16 | 13 | |
| 17 | 14 | |
| 18 | 88 | |
| 19 | 1 | |
| 20 | [ON CARCINOMA IN THE GASTRIC STUMP]. | 8 |
About Bryone J. Kuss
Bryone J. Kuss is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 86 papers that have together received 991 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (48 papers), Lymphoma Diagnosis and Treatment (27 papers) and Immunodeficiency and Autoimmune Disorders (12 papers). The work is most often cited by research in Genetics (500 citations), Hematology (279 citations) and Pathology and Forensic Medicine (357 citations). Bryone J. Kuss has collaborated with scholars based in Australia, United States and Italy. Frequent co-authors include Constantine S. Tam, Magdalena Sobieraj‐Teague, Craig T. Wallington‐Beddoe, Stuart M. Pitson, Sinoula Apostolou, Nicolas H. Voelcker, Paolo Ghia, Stephen Opat, Joi Ninomoto and Thomas J. Kipps. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.